DNA and RNA Quality Control
 
High quality samples are crucial for successful analysis. We provide quality control services of RNA and DNA using our Agilent’s Bioanalyzer and Agilent TapeStation systems. RNA quantification and purity can be performed using our NanoDrop. DNA quantification can also be asses using the Qubit or PicoGreen fluorometric assays.

 

Price examples

Bioanalyzer RNA Chip 12 samples : 1400 NOK*

TapeStation D1000 16 samples : 1400 NOK*

TapeStation HS D1000 16 samples : 1600 NOK*

TapeStation RNA 16 samples : 1400 NOK*

Please contact us to schedule sample delivery.

 

 * Price may vary due to fluctuations in currency exchange rate

 

 
 
 
 
 
 


News

Feb 24, 2016

The HiSeq 4000 build upon the existing HiSeq 2500 platform using the new HiSeq X patterned flow cell technology, providing unparalleled speed and performance. The dual-flow cell HiSeq 4000 System delivers the highest throughput and lowest price per sample across multiple applications. The new sequencer will provide users will faster turnaround time (run time is 3 days compared to 6-11 days in HiSeq 2500) and higher quality, more data per run and longer reads (150 bp paired-end).

Feb 15, 2016

The Oslo University Hospital Genomics and Bioinformatics Core Facilities will relocate to the new Oslo Cancer Cluster Innovation park to colocalise with the section for Molecular Pathology. The colocalisation will facilitate the technology and competence transfer from our genomics environment to accelerate the implementation of high-throughput sequencing for clinical stratification of cancer patients.


Contact Information:

oslo<at>genomics.no 

Visiting address:
Genomics Core Facility (Room 3-F8-04)
Department of Core facilities
Institute for Cancer Research
New OCCI-building 
 
Norwegian Radium Hospital 
Ullernchaussen 66, Lamell 3, 2B 
NO-0379 Oslo, NORWAY

+47 - 9183 2772 Laboratory
+47 - 9183 3425 Office

Head of Core Facility
Leonardo A. Meza-Zepeda, Dr. philos.

................................................................

................................................................